Comprehensive Services Providing Valuable Insights
Genetics at Oasis
You are unique and so is your genetic make up. Genetic screening can help guide us to live better and healthier lives. At Oasis MD, we have partnered with knowledgeable experts and accredited laboratories to bring the most accurate, trusted, and advanced testing within convenient reach.
Paint a more complete and personalized picture of your health and disease prevention with the power of genetic screening today.
Tests Offered
Non-invasive Prenatal Screening (NIPS/NIPT)
Coming Soon
Analyzes whether a pregnancy is at increased risk for chromosomal disorders. NIPS is recommended as a first tier screening test for common trisomies (21, 18, and 13) by the Society of Obstetricians and Gynecologists of Canada. This test must be done after 10 weeks of gestations. Whether testing is appropriate for your pregnancy should be discussed with your health care provider.
Conditions that can be tested include:
- Trisomy 13 (Patau syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 21 (Down syndrome)
- Sex chromosome aneuploidies
- Additional rare autosomal trisomies and microdeletion testing available as well
Complete Genetic Health Screening
This test is intended for use to screen individuals for hereditary conditions that, if detected early, may have effective medical interventions and preventive measures.
Conditions tested include:
- Cancers
- Cardiovascular diseases
- Metabolic diseases
- Other medically actionable conditions
167 genes tested
Cancer Genetic Screen
This test is meant for screening individuals for genetically susceptible conditions to hereditary cancers. If detected early there may be effective medical interventions or preventative measures.
Conditions tested include but not limited to:
- Breast cancer
- Colorectal cancer
- Cutaneous melanoma
- Gastric cancer
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Renal cell cancer
- Thyroid cancer
- Uterine cancer
- 65 genes tested
Cardiovascular Genetic Screen
This test is meant for screening individuals for hereditary cardiovascular conditions. If detected early there may be effective medical interventions or preventative measures.
Conditions tested include but not limited to:
- Aortopathies
- Arrhythmias
- Cardiomyopathies
- Genetic forms of high cholesterol
- Thrombophilia
Pharmacogenomics Testing
Analyzes a broad panel of genes that could impact clinical response to medications and is intended to aid clinicians with medication and dosage selection. Pharmacogenomic results should be used in combination with other clinical considerations and therapeutic drug monitoring to optimize treatment regimens and ensure safe medication use.
38 genes tested
*Prices show above may change without notice. Please inquire for up to date pricing.
All genetic screening tests are not comprehensive and does not include the entirety of all cancers or diseases stated above. Many cancers and heart conditions may genetic predispositions that does not have a genetic tests available.
All test specimens are shipped to a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).
EN 
ZH